Aster Dm Quality Care Ltd vs Molbio Diagnostics Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Aster DM Quality Care Ltd is ₹ 645 as of 23 Oct 15:30 . The P/E Ratio of Aster DM Quality Care Ltd changed from 46.2 on March 2021 to 89.7 on March 2026 . This represents a CAGR of 11.69% over 6 yearsThe P/E Ratio of Molbio Diagnostics Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Aster DM Quality Care Ltd changed from ₹ 6858 crore on March 2021 to ₹ 34794 crore on March 2026 . This represents a CAGR of 31.08% over 6 yearsThe Market Cap of Molbio Diagnostics Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 years The revenue of Aster DM Quality Care Ltd for the Jun '26 is ₹ 1347 crore as compare to the Mar '26 revenue of ₹ 1218 crore. This represent the growth of 10.57% The revenue of Molbio Diagnostics Ltd for the Jun '26 is ₹ 411.48 crore as compare to the Mar '26 revenue of ₹ 565.41 crore. This represent the decline of -27.22% The ebitda of Aster DM Quality Care Ltd for the Jun '26 is ₹ 178.58 crore as compare to the Mar '26 ebitda of ₹ 260.58 crore. This represent the decline of -31.47% The ebitda of Molbio Diagnostics Ltd for the Jun '26 is ₹ 103.68 crore as compare to the Mar '26 ebitda of ₹ 163.51 crore. This represent the decline of -36.59% The net profit of Aster DM Quality Care Ltd changed from ₹ 5152 crore to ₹ 29.28 crore over 9 quarters. This represents a CAGR of -89.95% The net profit of Molbio Diagnostics Ltd changed from ₹ -23.94 crore to ₹ 52.74 crore over 5 quarters. This represents a CAGR of NaN% The Dividend Payout of Aster DM Quality Care Ltd changed from 3818 % on March 2024 to 58.04 % on March 2026 . This represents a CAGR of -75.23% over 3 yearsThe Dividend Payout of Molbio Diagnostics Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Aster DM Quality Care Ltd

Aster DM Healthcare Limited was erstwhile established as 'Aster DM Healthcare Private Limited', a private limited company on 18 January, 2008.
On November 29, 2013.
The Company was converted into a public limited company and the name of the Company was changed to Aster DM Healthcare Limited. Aster DM Healthcare Limited is one of the leading healthcare player in the GCC and India.
Founded in 1987 by Dr. Azad Moopen, the Company has emerged as an integrated healthcare service organization that provides the complete circle of care to people through network of hospitals, clinics, labs and pharmacies, providing primary, secondary, tertiary to quaternary care to all segments of the population. Aster DM offer a diverse portfolio of specialised brands that serve patients in Primary, Secondary, Tertiary, and Quaternary Care, Healthcare Retailing, Diagnostic Laboratories, Digital Health, and Medical Education.

About Molbio Diagnostics Ltd

Molbio Diagnostics Limited was originally incorporated as Molbio Diagnostics Private Limited' at Panaji, as a private company dated October 20, 2000.
Thereafter, Company was converted from a private limited company to a public limited company, and the name of Company was changed to Molbio Diagnostics Limited, and a fresh certificate of incorporation dated January 16, 2025 was issued to Company by the RoC. Company is innovative point-of-care (POC) diagnostics company focused on expanding access to accurate, rapid and cost-effective healthcare technologies to diagnose infectious and non-communicable diseases.
The Company entered into a joint venture agreement in August, 2011 with Bigtec Innovations Private Limited and Bigtec Private Limited, which started operations in 2000.
Bigtec Innovations Private Limited got merged with the Company in 2015.

FAQs for the comparison of Aster DM Quality Care Ltd and null

Which company has a larger market capitalization, Aster DM Healthcare Ltd or Molbio Diagnostics Ltd?

Market cap of Aster DM Healthcare Ltd is 56,222 Cr while Market cap of Molbio Diagnostics Ltd is 14,262 Cr

What are the key factors driving the stock performance of Aster DM Healthcare Ltd and Molbio Diagnostics Ltd?

The stock performance of Aster DM Healthcare Ltd and Molbio Diagnostics Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Aster DM Healthcare Ltd and Molbio Diagnostics Ltd?

As of October 25, 2026, the Aster DM Healthcare Ltd stock price is INR ₹645.0. On the other hand, Molbio Diagnostics Ltd stock price is INR ₹1237.65.

How do dividend payouts of Aster DM Healthcare Ltd and Molbio Diagnostics Ltd compare?

To compare the dividend payouts of Aster DM Healthcare Ltd and Molbio Diagnostics Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.